What is FDA 21 CFR Part 11 and what does it require?

Study for the Clinical Research and Ethical Considerations Test. Enhance your understanding with multiple choice questions covering essential ethical guidelines and research methodologies. Prepare effectively for your test!

Multiple Choice

What is FDA 21 CFR Part 11 and what does it require?

Part 11 addresses how electronic records and electronic signatures are used in FDA-regulated activities and what controls must be in place to ensure trustworthiness. It establishes that electronic records should be as reliable and verifiable as paper records and that electronic signatures carry the same legal weight as handwritten ones. To meet these requirements, electronic systems must be validated to prove they work as intended and maintain record accuracy over time. Access must be protected with unique user identities and appropriate security so no one can misuse the system. The system must generate and maintain a secure, time-stamped audit trail showing who did what and when, making changes traceable and auditable. Electronic signatures must be linked to individuals and records, ensuring identity and binding the signature to the specific record. Documentation, standard operating procedures, and training are required to support compliance, along with proper retention and the ability to reproduce records during inspections. There are provisions for exemptions with certain legacy systems if they meet specific criteria, but the overarching goal is to ensure electronic records and signatures are trustworthy, authentic, and auditable. It’s not about animal testing, medical device labeling, or advertising, which are covered by different parts of FDA regulation.

Part 11 addresses how electronic records and electronic signatures are used in FDA-regulated activities and what controls must be in place to ensure trustworthiness. It establishes that electronic records should be as reliable and verifiable as paper records and that electronic signatures carry the same legal weight as handwritten ones.

To meet these requirements, electronic systems must be validated to prove they work as intended and maintain record accuracy over time. Access must be protected with unique user identities and appropriate security so no one can misuse the system. The system must generate and maintain a secure, time-stamped audit trail showing who did what and when, making changes traceable and auditable. Electronic signatures must be linked to individuals and records, ensuring identity and binding the signature to the specific record. Documentation, standard operating procedures, and training are required to support compliance, along with proper retention and the ability to reproduce records during inspections. There are provisions for exemptions with certain legacy systems if they meet specific criteria, but the overarching goal is to ensure electronic records and signatures are trustworthy, authentic, and auditable.

It’s not about animal testing, medical device labeling, or advertising, which are covered by different parts of FDA regulation.

More practice questions